Pipeline

We aim to provide safe, effective and accessible treatment solutions for patients worldwide.

Fourth-generation MAO-B inhibitor New chemical entity

Parkinson's disease (PD) is a prevalent neurodegenerative disorder, which cannot be completely cured by current medications. Abnormal metabolism of dopamine

Positive allosteric modulator of GABAA receptors New chemical entity

Postpartum depression, refractory epilepsy

IDO1/TDO dual inhibitor New chemical entity

Inflammatory depression

GABAB receptor agonist Old drugs for new uses

Amyotrophic lateral sclerosis, spastic pain

CGRP antagonist New chemical entity

Migraine and complex comorbidities

ALK regulator New chemical entity

Glioma

ALK degrader New chemical entity

ALK-positive lung cancer/ lymphoma